LIGASURE™ TECHNOLOGY

Thoracic Surgery

Confidence.
When you need it most.

LigaSure™ technology has been used in more than 25 million procedures worldwide.¹

The LigaSure™ Maryland jaw thoracic device (LF1930T) is the first and only minimally invasive LigaSure™ device on the market specifically indicated for sealing pulmonary veins and arteries/vessels up to, and including, 7 mm.²

"7 Reasons Why" you want to bring the Right Energy to your thoracic cases with the Ligasure™ Maryland jaw thoracic device (LF1930T):

Reliable Hemostasis

For 7 mm pulmonary vasculature, the device also seals and transects adhesions.^2-8

Improved Access

30 cm shaft designed specifically for access to the thoracic cavity.^4–8

Multifunctionality

The device has the benefits of being a Maryland dissector^9,11, one – step sealer¹³, atraumatic grasper^9,11. cold scissors^9,13 and it may reduce instrument exchanges^9,10 and procedure time^9,14.

Effective Blunt Dissection

For dissecting around the recurrent nerve and lymph nodes without causing damage^9,11

Cooler Jaws

Cooler Jaws

Cooler jaw temperature and faster cool down times compared to Harmonic HD1000i^™*9,12,§.

Coated Jaws

Proprietary nano‑coating on the jaws to reduce sticking^9,15,Φ, eschar buildup^15,16 and cleanings^9,17,Ω.

Better Visualization

The curved jaw allows for better access, visualization and easy skeletonization of vessels^9,10.

We're working hard to transform lung health - from identifying patients earlier to optimizing treatment to accelerating recovery. It's why we're committed to offering a comprehensive suite of technologies tailored for thoracic surgery.

View Product Page

VATs procedure with LigaSure™ Maryland Thoracic and Dr Congregado

VATS procedure LigaSure™ Maryland Thoracic and Dr Scarci

Dr. Scarci testimonial

THORACIC SURGERY WITH ADVANCED ENERGY

Now, thoracic surgeons can use an advanced energy device made specifically for their procedures.^1,2,3,4,5

It can help you:

Seal and divide pulmonary veins and arteries up to and including 7mm²
Seal and transect adhesions^2-8
Dissect lymph nodes^9,11

Reliable LigaSure™ technology comes to Lung Health. That's good news for surgeons - and your patients.

LigaSure™ Maryland Thoracic - 7 Reasons Why Brochure

View Now

The LigaSure™ Maryland thoracic device provides:

A one-step vessel sealer¹³
A Maryland dissector for enhanced blunt dissection^9,11
An attraumatic grasper to securely grasp tissue^9,11
Cold scissors to leave the critical decision to cut in the surgeon's hands^9,13

Contact us for more information

† Based on a US database search of Ethicon Enseal, Harmonic, Olympus Thunderbeat, Medtronic, Applied Medical, Aesculap devices (March 10, 2019).
§ Based on systemic vasculature.
Φ Tissue sticking to device jaws instances measured over 110 seals per device (ForceTriad™ energy platform). F1930T is only compatible with the Valleylab™ FT10 energy platform.
Ω Cleaning effectiveness assessed after each of two cleaning cycles.
1. Based on internal sales data from FY01‑FY20. October 2019.
2. Based on internal report #RE00147462, Pulmonary sealing claims for the LigaSure™ LF1930T device (memo). March 29, 2018.
3. LigaSure™ Maryland Jaw Thoracic Sealer/Divider, Nano‑Coated [instructions for use]. Boulder, CO: Medtronic; 2017. ±As of Nov. 19, 2018, based on indications for use for laparoscopic LigaSure™ devices.
4. Based on internal report #RE00138840, LIG‑45 memo, device length recommendation, thoracic (LF1930T). Feb. 6, 2018.
5. Based on internal test report #RE00125866, Jaw force and gap range burst pressure evaluation of EB4 thoracic Maryland device (LF1930T); conducted on bovine tissue. Nov. 20 –21, 2017 and Nov. 27–30, 2017.
6. Based on internal test report #RE00134865, Burst pressure verification of pulmonary bovine veins using the LigaSure™ LF1930T device. Jan. 17–18, 2018.
7. Based on internal test report #RE00122515, Verification of the LigaSure™ LF1930T device in a GLP chronic hemostasis canine study on pulmonary vasculature. Jan. 8–10, 2018.
8. Based on internal test report #RE00128442, GLP acute pulmonary vasculature hemostasis verification study of the LigaSure™ LF1930T device in hounds. Dec. 8, 2017
9. Based on internal test report #RE00140529 rev A, LigaSure™ Maryland device, nano‑coated (LF19X X) tissue testing (memo). March 5, 2018
10. Based on internal test report #RE00071598, Maryland validation labs, Houston and Los Angeles: independent surgeon feedback collected during porcine labs. April 16–18 and April 30 –May 3, 2013. ≠ 30 of 33 surgeons surveyed after use.
11. Based on internal test report #R0035742, Maryland validation, Houston and Los Angeles: independent surgeon feedback collected during porcine labs. April 16–18 and April 30–May 3, 2013.
12. Based on internal test report #R0032385 rev A, Thermal profile comparison of Ethicon Harmonic™* HD1000i shears versus nano‑coated LigaSure™ Maryland jaw device on the Valleylab™ FT10 energy platform. May 17–18, 2017 and June 14, 2017.
13. LigaSure™ Maryland Jaw Sealer/Divider, Nano‑Coated [instructions for use]. Boulder, CO: Medtronic; 2016.
14. Okada M, Miyata Y, Takamochi K, Tsutani Y, Oh S, Suzuki K. Prospective feasibility study of sealing pulmonary vessels with energy in lung surgery. J Thorac Cardiovasc Sur. 2018.
15. Based on internal test report #RE00073194, Tissue sticking comparison of the Ethicon G2™*, Voyant™* 5 mm Fusion, LigaSure™ LF1737, and LigaSure™ LF1937 devices conducted on porcine tissue using the ForceTriad™ energy platform. Jan. 18, 2017.
16. Based on internal report #RE00147462, Pulmonary sealing claims for the LigaSure™LF1930T device (memo). March 29, 2018.
17. Based on internal test report #RE00071599, LF19XX MJC marketing claims testing conducted on porcine tissue, Feb. 7–22, 2017.

CORPORATE RESOURCES

Minimally Invasive Therapies

©2021 Medtronic